Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07226245
PHASE4

Methadone Pharmacokinetics in Cardiac Surgery

Sponsor: Wake Forest University Health Sciences

View on ClinicalTrials.gov

Summary

Cardiac surgery frequently leads to significant postoperative pain, with multiple different drug regimens being utilized (both opioid and non-opioid) in an attempt to alleviate this surgical pain. Methadone is currently one of the drugs that is being utilized to help control the pain. It can be given during and/or after surgery. This study hopes to identify the optimal dose of methadone to use to treat this surgical pain.

Official title: Evaluating Pharmacokinetics of Three Methadone Dosing Strategies During Cardiac Surgery With Cardiopulmonary Bypass

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

69

Start Date

2026-05

Completion Date

2026-12-30

Last Updated

2026-03-27

Healthy Volunteers

No

Interventions

DRUG

Single dose of methadone

Single dose of methadone 0.3 mg/kg actual body weight (max 30 mg) administered at induction of anesthesia

DRUG

Split dose of methadone

Split dose of methadone 0.2 mg/kg actual body weight at induction and 0.1 mg/kg actual body weight post cardiopulmonary bypass

DRUG

Balanced split dose of methadone

Balanced split dose of methadone 0.15 mg/kg actual body weight at induction and 0.15 mg/kg actual body weight post cardiopulmonary bypass

Locations (1)

Wake Forest University Health Sciences

Winston-Salem, North Carolina, United States